104 related articles for article (PubMed ID: 1895617)
1. [Treatment of renal cell carcinoma with human lymphoblastoid interferon alpha and UFT in combination. A prospective multicenter trial].
Akaza H; Kameyama S; Kanemura M; Kitajima K; Homma Y; Kawamura T; Okada K; Murahashi I; Kawabe K; Isurugi K
Nihon Hinyokika Gakkai Zasshi; 1991 Jul; 82(7):1053-8. PubMed ID: 1895617
[TBL] [Abstract][Full Text] [Related]
2. [Antitumor activity of UFT and interferon-alpha against human renal cell carcinoma in athymic nude mice].
Yanase I; Shirahama T; Kayajima T; Ohi Y
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):709-12. PubMed ID: 3128184
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy of human renal cell carcinoma in athymic nude mice with human lymphoblastoid interferon (HLBI) and UFT, 5-Fu].
Yamada Y; Muramatsu T; Honda N; Fukatsu H; Segawa A; Hirata N; Senda H
Hinyokika Kiyo; 1990 May; 36(5):527-34. PubMed ID: 2119093
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study of renal cell carcinoma].
Yamada Y; Fukatsu H; Honda N; Miyagawa Y; Segawa A
Hinyokika Kiyo; 1993 Dec; 39(12):1197-203. PubMed ID: 7506869
[TBL] [Abstract][Full Text] [Related]
5. [Successful management for advanced renal cell carcinoma under combination therapy with human lymphoblastoid interferon-alpha and UFT (mixture of tegafur and uracil): a case report].
Kanno H; Kitami K; Senga Y; Takahashi T; Nagashima Y
Hinyokika Kiyo; 1993 Aug; 39(8):725-9. PubMed ID: 8379474
[TBL] [Abstract][Full Text] [Related]
6. [Combination therapy of renal cell carcinoma with interferon-alpha and UFT (or FT-207)].
Kobayashi M; Imai K; Yamanaka H; Takahashi H; Mashimo T; Shimizu N; Koya J; Yajima H; Kawashima K; Kitaura K
Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1437-46. PubMed ID: 2509605
[TBL] [Abstract][Full Text] [Related]
7. [Collaborative study of UFT in far-advanced renal cell carcinoma. Urological Cooperative UFT Study Group].
Niijima T; Aso Y; Akaza H; Kameyama S; Koiso K; Kawabe K; Kawamura T; Isurugi K; Yokoyama M; Shoji F
Gan To Kagaku Ryoho; 1988 Jan; 15(1):109-14. PubMed ID: 3122664
[TBL] [Abstract][Full Text] [Related]
8. [Long-term complete response of multiple lung metastases from renal cell carcinoma induced by combination therapy with interferon alpha and UFT: a case report].
Terachi T; Okada Y; Takeuchi H; Yoshida O
Hinyokika Kiyo; 1993 Apr; 39(4):353-5. PubMed ID: 8503332
[TBL] [Abstract][Full Text] [Related]
9. Treatment of metastatic renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.
Kotake T; Kinouchi T; Saiki S; Kuroda M; Miki T; Kiyohara H; Usami M
Jpn J Clin Oncol; 1991 Feb; 21(1):46-51. PubMed ID: 2067120
[TBL] [Abstract][Full Text] [Related]
10. [A case of pulmonary metastasis from renal cell carcinoma with complete response to interferon-alpha and tegafur/uracil (UFT) but possibly UFT-induced liver dysfunction and leukoencephalopathy-like symptoms].
Suzuki K; Nukui A; Kobayashi M; Sugaya Y; Muraishi O; Morita T; Tokue A
Hinyokika Kiyo; 1999 Sep; 45(9):621-4. PubMed ID: 10540708
[TBL] [Abstract][Full Text] [Related]
11. [Tumor reduction in advanced renal cell carcinoma with tumor thrombus by renal embolization, interferon-alpha and UFT. A case report].
Shiomi K; Kamura K; Seto K; Hamaguchi K; Matsushita K; Yamauchi T
Hinyokika Kiyo; 1997 Mar; 43(3):217-21. PubMed ID: 9127758
[TBL] [Abstract][Full Text] [Related]
12. [Therapy on pulmonary metastasis of renal cell carcinoma].
Hara M; Kawamura N; Hasegawa J; Akimoto M
Hinyokika Kiyo; 1990 Oct; 36(10):1125-9. PubMed ID: 2148250
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor activity of UFT against murine renal cell carcinoma: a study on the suppression tumor metastases].
Fujioka T; Hasegawa M; Ishikura K; Nomura K; Okamoto T; Tanji S; Koike H; Kubo T
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2031-6. PubMed ID: 2221926
[TBL] [Abstract][Full Text] [Related]
14. [Complete remission of lung metastasis of renal cell carcinoma by (UFT) therapy].
Sugawara T; Sakuramoto T; Fukushima S
Hinyokika Kiyo; 1987 Aug; 33(8):1232-5. PubMed ID: 3122543
[TBL] [Abstract][Full Text] [Related]
15. Report on nationwide pooled data and cohort investigation in UFT phase II study.
Ota K; Taguchi T; Kimura K
Cancer Chemother Pharmacol; 1988; 22(4):333-8. PubMed ID: 3139315
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of UFT chemotherapy in renal cancer. Kyushu University Cooperative Study Group of Renal Cancer].
Ueda T; Kumazawa J; Ohmori A; Sakamoto K; Aito K; Morita I; Ohta Y; Takesue T; Hara S; Sagiyama K
Gan To Kagaku Ryoho; 1990 Feb; 17(2):239-43. PubMed ID: 2105698
[TBL] [Abstract][Full Text] [Related]
17. [Effects of UFT in advanced renal cell cancer].
Koseki K; Akaza H; Kishi H; Umeda T; Isurugi K; Niijima T
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2061-4. PubMed ID: 3931562
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma].
Nakagami Y; Lin TT; Ito H; Hirasawa S; Tannawa K; Fujioka Y; Ogawa H; Tanaka K; Yamada N; Ishii Y
Hinyokika Kiyo; 1987 Oct; 33(10):1728-32. PubMed ID: 3128071
[TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial.
Porzsolt F; Messerer D; Hautmann R; Gottwald A; Sparwasser H; Stockamp K; Aulitzky W; Moormann JG; Schumacher K; Rasche H
J Cancer Res Clin Oncol; 1988; 114(1):95-100. PubMed ID: 2965154
[TBL] [Abstract][Full Text] [Related]
20. Stratification by risk factors predicts survival on the active treatment arm in a randomized phase II study of interferon-gamma plus/minus interferon-alpha in advanced renal cell carcinoma (E6890).
Dutcher JP; Fine JP; Krigel RL; Murphy BA; Schaefer PL; Ernstoff MS; Loehrer PJ
Med Oncol; 2003; 20(3):271-81. PubMed ID: 14514977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
